Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 2
1978 2
1980 4
1981 3
1982 5
1983 2
1984 4
1985 1
1986 1
1987 3
1988 6
1989 5
1990 7
1991 8
1992 12
1993 13
1994 11
1995 11
1996 19
1997 6
1998 19
1999 16
2000 18
2001 28
2002 45
2003 56
2004 52
2005 77
2006 77
2007 104
2008 122
2009 160
2010 163
2011 214
2012 226
2013 234
2014 284
2015 307
2016 245
2017 262
2018 294
2019 292
2020 391
2021 529
2022 470
2023 432
2024 187

Text availability

Article attribute

Article type

Publication date

Search Results

4,824 results

Results by year

Filters applied: . Clear all
Page 1
CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics.
Bhardwaj S, Kesari KK, Rachamalla M, Mani S, Ashraf GM, Jha SK, Kumar P, Ambasta RK, Dureja H, Devkota HP, Gupta G, Chellappan DK, Singh SK, Dua K, Ruokolainen J, Kamal MA, Ojha S, Jha NK. Bhardwaj S, et al. Among authors: jha sk, jha nk. J Adv Res. 2022 Sep;40:207-221. doi: 10.1016/j.jare.2021.07.001. Epub 2021 Jul 6. J Adv Res. 2022. PMID: 36100328 Free PMC article. Review.
BACKGROUND: Alzheimer's disease (AD) is an insidious, irreversible, and progressive neurodegenerative health condition manifesting as cognitive deficits and amyloid beta (Abeta) plaques and neurofibrillary tangles. ...AIM OF REVIEW: This review aims to provide a deep insig …
BACKGROUND: Alzheimer's disease (AD) is an insidious, irreversible, and progressive neurodegenerative health condition manifesting as …
Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress.
Dewanjee S, Chakraborty P, Bhattacharya H, Chacko L, Singh B, Chaudhary A, Javvaji K, Pradhan SR, Vallamkondu J, Dey A, Kalra RS, Jha NK, Jha SK, Reddy PH, Kandimalla R. Dewanjee S, et al. Among authors: jha sk, jha nk. Free Radic Biol Med. 2022 Nov 20;193(Pt 1):134-157. doi: 10.1016/j.freeradbiomed.2022.09.032. Epub 2022 Oct 4. Free Radic Biol Med. 2022. PMID: 36206930 Review.
Increasing evidence suggests that abnormal cerebral glucose metabolism is largely present in Alzheimer's disease (AD). The brain utilizes glucose as its main energy source and a decline in its metabolism directly reflects on brain function. ...
Increasing evidence suggests that abnormal cerebral glucose metabolism is largely present in Alzheimer's disease (AD). The brain util …
International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology.
Mehta RL, Cerdá J, Burdmann EA, Tonelli M, García-García G, Jha V, Susantitaphong P, Rocco M, Vanholder R, Sever MS, Cruz D, Jaber B, Lameire NH, Lombardi R, Lewington A, Feehally J, Finkelstein F, Levin N, Pannu N, Thomas B, Aronoff-Spencer E, Remuzzi G. Mehta RL, et al. Among authors: jha v. Lancet. 2015 Jun 27;385(9987):2616-43. doi: 10.1016/S0140-6736(15)60126-X. Epub 2015 Mar 13. Lancet. 2015. PMID: 25777661 Review. No abstract available.
Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements.
Raina R, Jothi S, Haffner D, Somers M, Filler G, Vasistha P, Chakraborty R, Shapiro R, Randhawa PS, Parekh R, Licht C, Bunchman T, Sethi S, Mangat G, Zaritsky J, Schaefer F, Warady B, Bartosh S, McCulloch M, Alhasan K, Swiatecka-Urban A, Smoyer WE, Chandraker A, Yap HK, Jha V, Bagga A, Radhakrishnan J. Raina R, et al. Among authors: jha v. Kidney Int. 2024 Mar;105(3):450-463. doi: 10.1016/j.kint.2023.10.017. Epub 2023 Dec 22. Kidney Int. 2024. PMID: 38142038 Review.
Author's reply.
Jha V. Jha V. Indian J Nephrol. 2012 May;22(3):229-30. Indian J Nephrol. 2012. PMID: 23087565 Free PMC article. No abstract available.
Implications of Microorganisms in Alzheimer's Disease.
Yadav P, Lee YH, Panday H, Kant S, Bajwa N, Parashar R, Jha SK, Jha NK, Nand P, Lee SS, Jha AK. Yadav P, et al. Among authors: jha ak, jha sk, jha nk. Curr Issues Mol Biol. 2022 Sep 30;44(10):4584-4615. doi: 10.3390/cimb44100314. Curr Issues Mol Biol. 2022. PMID: 36286029 Free PMC article. Review.
Alzheimer's disease (AD) is a deadly brain degenerative disorder that leads to brain shrinkage and dementia. ...
Alzheimer's disease (AD) is a deadly brain degenerative disorder that leads to brain shrinkage and dementia. ...
Author's reply.
Srivastava A, Jha MS. Srivastava A, et al. Among authors: jha ms. Indian J Urol. 2007 Oct;23(4):481. doi: 10.4103/0970-1591.36894. Indian J Urol. 2007. PMID: 19718311 Free PMC article. No abstract available.
4,824 results